Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
WMJ ; 121(3): E42-E45, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2083741

ABSTRACT

INTRODUCTION: COVID-19 has been associated with neurological complications, including encephalopathy and akinetic mutism. CASE PRESENTATION: A 7-year-old unvaccinated boy presented with visual hallucinations, urinary incontinence, and akinetic mutism 13 days after he was exposed to COVID-19. He had minimal respiratory symptoms, including just 1 day of fever and cough. Evaluations showed slowing on electroencephalogram, normal cerebrospinal fluid, normal brain magnetic resonance imaging, and mild sinus bradycardia. He recovered rapidly to baseline after 5 days of intravenous methylprednisolone. DISCUSSION: COVID-19-related encephalopathy including akinetic mutism is usually found in older adult patients with more severe COVID-19 illness. Our case demonstrates that akinetic mutism can present in children with mild COVID-19 illness and that it can respond rapidly and completely to intravenous methylprednisolone. CONCLUSIONS: COVID-19-related encephalopathy may be immune mediated. A heightened awareness of its association with COVID-19 illness should lead to earlier diagnosis and consideration of immunomodulatory therapy.


Subject(s)
Akinetic Mutism , COVID-19 , Male , Child , Humans , Aged , Akinetic Mutism/drug therapy , Akinetic Mutism/etiology , Akinetic Mutism/diagnosis , COVID-19/complications , Magnetic Resonance Imaging/adverse effects , Methylprednisolone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL